MedPath

Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery Patients

Phase 4
Terminated
Conditions
Surgical Site Infection
Interventions
Other: Theraworx Bath Wipes
Drug: Chlorhexidine Gluconate 2% Wipe
Registration Number
NCT03401749
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

Intervention: This study will involve three different study arms with different interventions prior to surgery: (1) shower only, (2) shower plus Theraworx wipes, (3) shower plus chlorhexidine wipes

Study Design: Single center RCT

Sample Size: 500 patients, aged 18+

Objectives: Primary Objectives:

1. Monitor for safety and adverse effects.

2. Evaluate for differences in peri-operative skin cultures between treatment groups;

3. Compare surgical site infection rates between groups.

Secondary Objectives:

1. Assess for patient compliance for each different treatment arms.

2. Measure patient satisfaction.

3. Measure nurse satisfaction.

4. Visual assessment of wound healing

Expected Results: We expect no statistically significant difference in peri-operative cultures or surgical site infection rates between groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
203
Inclusion Criteria
  • Adult patient between ages 18-64
  • Scheduled and deemed healthy enough to undergo orthopaedic surgery
  • Willing and able to comply with protocol
Read More
Exclusion Criteria
  • Clinical signs of infection
  • Contraindication to CHG or Theraworx
  • Previous allergic reaction to CHG or Theraworx
  • Surgeon's Discretion
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Theraworx GroupTheraworx Bath WipesUsual preadmission surgery instructions (shower the night before) plus theraworx skin wipe system use the night before surgery and 1 hour before surgery.
CHG GroupChlorhexidine Gluconate 2% WipeUsual preadmission surgery instructions (shower the night before) plus chlorhexidine gluconate (CHG) skin wipe system use the night before surgery and 1 hour before surgery.
Primary Outcome Measures
NameTimeMethod
Number of Participants That Developed a Surgical Site InfectionWithin 1 year of Surgery

Clinical development of a surgical site infection in the postoperative period.

Secondary Outcome Measures
NameTimeMethod
Number of Patients Compliant With the Requirement of Their Study GroupDay before and day of surgery

Survey on patient's ability to follow the study guidelines. For example, if the patient was placed in the Theraworx study group, did they properly follow the instructions to shower and use the Theraworx skin wipe system the night before surgery.

Trial Locations

Locations (1)

UAB Highlands Hospital

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath